Covid-19 Vaccine Booster Dose and The Indian Scenario: When We Will Have a Fully Immunized Population?
Keywords:COVID-19, Booster dose, Indian scenario
Fisher KA, Nguyen N, Fouayzi H, Crawford S, Singh S, Dong M, et al. From COVID-19 Vaccine Hesitancy to Vaccine Ac-ceptance: Results of a Longitudinal Survey. Public Health Re-ports. 2023;0(0). Doi: https://doi.org/10.1177/00333549231176006 PMid:37243439 PMCid:PMC10235915
Masthi Nr R, Brahmajosyula A, Khamar A, Acharya N, Bili-chod LP, Kondath D. Coverage of Coronavirus Disease-2019 (COVID-19) Booster Dose (Precautionary) in the Adult Popu-lation: An Online Survey. Cureus. 2022 Jul 16;14(7): e 26912. Doi: https://doi.org/10.7759/cureus.26912 PMid:35983381 PMCid:PMC9376214
Precaution Dose to be now available to 18+ population group from 10th April, 2022, at Private Vaccination Centres Posted On: 08 APR 2022 3:01PM by Ministry of Health and Family Welfare https://pib.gov.in/PressReleasePage.aspx?PRID= 1814804 Last accessed on 1st March 2023.
Bhaumik S, MUKHIDA S, Das N, Khan S, Patil R, Kannuri S. Can Vaccines Alone Bring an End to This Pandemic? Natl J Com-munity Med. 2023 Mar. 31 [cited 2023Jun.1];14(03):208-9. Doi: https://doi.org/10.55489/njcm.140320232647
Mukhida S, Kannuri S, Das NK, Khan S, Patil R. Is a vaccine one of the factors that will contribute to the end of the Pandemic? Iranian Journal of Medical Microbiology. 2023.06.08 (ahead of Print).
Vaccine State Data published on Ministry of the Health and Family Welfare data checked on 1st March 2023. Available on https://www.mohfw.gov.in/ last accessed on 1st March 2023.
Gupta A, Bhoyar R, Mirza S, Jolly B, Senthivel V, Shamnath A, et al. SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker. J Infect. 2022; 84(3):418-467. Doi: https://doi.org/10.1016/j.jinf.2021.10.008 PMid:34678389 PMCid:PMC8523545
Mukhida S, Vyawahare C, Verma P, Khan S, Das N. Are the Cur-rent COVID-19 Cases Post-Phase of 3rd Wave or Pre-phase of 4th Wave in India? Iran J Med Microbiol 2023; 17 (2):270-272. Doi: https://doi.org/10.30699/ijmm.17.2.270
Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology. https://pib.gov.in/ Press ReleasePage.aspx?PRID=1933586.
How to Cite
Copyright (c) 2023 Amitesh Datta, Sahjid Mukhida, Sundip Mukherjee , Akash Korat, Sameena Khan, Preethy Edavaloth
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The author retains the copyright of their article, with first publication rights granted to Medsci Publications.